Development and validation of ACTE-MTB: A tool to systematically assess the maturity of molecular tumor boards

Tara M Love1, Daniel A Anaya2, Matthew S Prime3

  • 1Roche Information Solutions, Roche Diagnostics Corporation, Santa Clara, California, United States of America.

Plos One
|May 13, 2022
PubMed